In 1985, Novo Nordisk introduced the first NovoPen®, revolutionising the modern treatment of diabetes and improving the quality of life for people with diabetes.
NovoPen® 3 is suited for all types of regimens including intensive therapy, since the different colour versions allow easy differentiation of insulin type.
NovoPen® 3 is a registered trademark of Novo Nordisk A/S.
HQMMA/DV/1014/0060. November 2014.